NICHEY

HR+/HER2- Breast Cancer: The Global Shift in Research and Market Dynamics | #healthcare

Loading..

Watch

Watch Reels

Events

Browse Events My events

Blog

Browse articles

Market

Latest Products

Pages

My Pages Liked Pages

More

Forum Explore Popular Jobs Offers Fundings
Reels Watch Events Market Blog My Pages See all

k kumar
k kumar  created a new article
1 y

HR+/HER2- Breast Cancer: The Global Shift in Research and Market Dynamics | #healthcare

Other

HR+/HER2- Breast Cancer: The Global Shift in Research and Market Dynamics

HR+ HER2- breast cancer is the most common subtype, making up around 70% of all breast cancer cases. Characterized by hormone receptor positivity and the absence of HER2 overexpression, the prevalence of HR+ HER2- breast cancer varies globally.
Like
Latest Products See all